Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

Low Risk

Score: 25/100

Failure Rate

0.0%

0 terminated/withdrawn out of 6 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

50%

3 trials in Phase 3/4

Results Transparency

0 of 4 completed trials have results

Key Signals

2 recruiting

Enrollment Performance

Analytics

N/A

2(40.0%)

Phase 4

2(40.0%)

Phase 3

1(20.0%)

5Total

N/A(2)

Phase 4(2)

Phase 3(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (6)

Showing 6 of 6 trials

NCT07318766Not ApplicableCompleted

Incentive Spirometer in Liver Transplant Recipients

Role: collaborator

NCT07289555Not ApplicableRecruiting

Tailored Stapled SADI-S: Initial Report and Preliminary Results

Role: lead

NCT06591377Phase 3Recruiting

Combining Aspirin With Ticagrelor or Cilostazol in Large-vessel Minor Stroke or TIA

Role: collaborator

NCT04997707Phase 4Completed

The Effect of Balanced Anesthesia Regimen on Intraoperative Trans-cranial Motor Evoked Potential During Spine Surgeries:

Role: lead

NCT04561895Completed

Adipokine Genetic Variations in predictingNAFLD Progression to NASH in Egyptian Patients

Role: collaborator

NCT03318471Phase 4Completed

Magnesium Sulphate for Attenuation of Hemodynamic Pressor Response After Myfield's Clamp Application

Role: lead

All 6 trials loaded